bnf mart
SKU: B00740227
A+

1. COMPOSITION
Each film-coated tablet conta......

1. COMPOSITION
Each film-coated tablet contains
Lamivudine         USP        150mg
Zidovudine            BP        300mg
Nevirapine          USP        200mg


2. INDICATIONS:
TROVIR is indicated for the treatment of HIV infection, once patients have been stabilized on the maintenance regimen of nevirapine 200mg bd, and have demonstrated adequate tolerability to nevirapine.


3. CONTRAINDICATIONS:
TROVIR is contraindicated in patients with clinically significant hypersensitivity to any of the components contained in the formulation.[more]
TROVIR is also contraindicated for patients who are just initiating therapy with nevirapine. These patients require a lead-in dose of nevirapine 200 mg o.d., whereas this formulation contains the maintenance dose of nevirapine 200 mg b.d. (see Indications).Thus, it is recommended that patients initiate therapy using a combination of LASOVIR and NIVEPIN during the first two weeks, and then switch to TROVIR once adequate tolerability is demonstrated.


4. Side Effects
LAMIVUDINEPancreatitis, Lactic acidosis and hepatic steatosis, hepatits and liver failure diarrhea, malaise and fatigue, headache, nausea and
vomiting, abdominal pain and discomfort, peripheral neuropathy, arthralgias, myalgias, skin rash, pruritus, transient neutropenia and thrombocytopenia and rarely, pancreatitis.
ZIDOVUDINEFever, headache, nausea, vomiting, anorexia, myalgia, insomnia, dizziness, paraesthesias, dyspnoea and rash. Malaise, gastrointestinal pain, dyspepsia and taste perversion neutropenia, lucopenia.
NEVIRAPINErash and increases in liver enzymes, hypersensitivity reactions mild to moderate, maculopapular erythematous cutaneous eruptions


5. DOSAGE AND ADMINISTRATION
Adults
1 tablet twice daily for patients weighing < 60 kg
TROVIR should not be administered to patients who have just initiated therapy with nevirapine. This is because an initial lead-in dosing of 200 mg nevirapine once daily for 2 weeks is recommended. Following this lead-in dose, a dose escalation (maintenance dose) to 200mg nevirapinebd may be carried out in the absence of any hypersensitivity reactions (e.g. rash, liver function test abnormalities; see Warnings and Precautions).


This medicine is Prescription Only Medicine (POM ) and required under medical supervision.

ဤဆေးသည် POM ဆေးအုပ်စုတွင်ပါဝင်သောကြောင့် ဆရာဝန်ညွှန်ကြားချက်အတိုင်းသာ သုံးစွဲသင့်ပါသည်။

Read more

Size : 6 x 10’s = 60 tablets

Rated 5.00 out of 5 based on 1 customer rating
(0 customer review)
1 × 38,950 Ks

[ 1 × 38,950 Ks ]

Description

Trovir

1. COMPOSITION
Each film-coated tablet contains
Lamivudine         USP        150mg
Zidovudine            BP        300mg
Nevirapine          USP        200mg


2. INDICATIONS:
TROVIR is indicated for the treatment of HIV infection, once patients have been stabilized on the maintenance regimen of nevirapine 200mg bd, and have demonstrated adequate tolerability to nevirapine.


3. CONTRAINDICATIONS:
TROVIR is contraindicated in patients with clinically significant hypersensitivity to any of the components contained in the formulation.[more]
TROVIR is also contraindicated for patients who are just initiating therapy with nevirapine. These patients require a lead-in dose of nevirapine 200 mg o.d., whereas this formulation contains the maintenance dose of nevirapine 200 mg b.d. (see Indications).Thus, it is recommended that patients initiate therapy using a combination of LASOVIR and NIVEPIN during the first two weeks, and then switch to TROVIR once adequate tolerability is demonstrated.


4. Side Effects
LAMIVUDINEPancreatitis, Lactic acidosis and hepatic steatosis, hepatits and liver failure diarrhea, malaise and fatigue, headache, nausea and
vomiting, abdominal pain and discomfort, peripheral neuropathy, arthralgias, myalgias, skin rash, pruritus, transient neutropenia and thrombocytopenia and rarely, pancreatitis.
ZIDOVUDINEFever, headache, nausea, vomiting, anorexia, myalgia, insomnia, dizziness, paraesthesias, dyspnoea and rash. Malaise, gastrointestinal pain, dyspepsia and taste perversion neutropenia, lucopenia.
NEVIRAPINErash and increases in liver enzymes, hypersensitivity reactions mild to moderate, maculopapular erythematous cutaneous eruptions


5. DOSAGE AND ADMINISTRATION
Adults
1 tablet twice daily for patients weighing < 60 kg
TROVIR should not be administered to patients who have just initiated therapy with nevirapine. This is because an initial lead-in dosing of 200 mg nevirapine once daily for 2 weeks is recommended. Following this lead-in dose, a dose escalation (maintenance dose) to 200mg nevirapinebd may be carried out in the absence of any hypersensitivity reactions (e.g. rash, liver function test abnormalities; see Warnings and Precautions).


This medicine is Prescription Only Medicine (POM ) and required under medical supervision.

ဤဆေးသည် POM ဆေးအုပ်စုတွင်ပါဝင်သောကြောင့် ဆရာဝန်ညွှန်ကြားချက်အတိုင်းသာ သုံးစွဲသင့်ပါသည်။

Reviews

0
0
0
0
0
0

Add a review